Increased inflammation with crude E. coli LPS protects against acute leptospirosis in hamsters-Reference-Cited by-同舟云学术

Increased inflammation with crude E. coli LPS protects against acute leptospirosis in hamsters

Published:2020-01-01 Issue:1 Volume:9 Page:140-147
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Zhang Wenlong¹²,Xie Xufeng¹²,Wang Jiaqi¹,Song Ning¹,Lv Tianbao¹,Wu Dianjun¹,Zhang Naisheng¹,Cao Yongguo¹²

Affiliation:

1. Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, People’s Republic of China

2. Key Laboratory for Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, People’s Republic of China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2019.1710435

Reference26 articles.

1. Leptospirosis: A Silent Epidemic Disease

2. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase

3. Leptospirosis: a zoonotic disease of global importance

4. Cathelicidin Insufficiency in Patients with Fatal Leptospirosis

5. 2010 ACVIM Small Animal Consensus Statement on Leptospirosis: Diagnosis, Epidemiology, Treatment, and Prevention

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;eLife;2024-05-31

2. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;eLife;2024-05-31

3. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;2024-05-20

4. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;2024-03-05

5. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;2024-01-18